# Allogeneic γδT Cells in Glioblastoma

> **NCT07144735** · NA · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Glioblastoma (GBM)
- Glioblastoma Multiforme (GBM)

## Interventions

- **DRUG:** Allogeneic γδ T (ABOUT) cells

## Key facts

- **NCT ID:** NCT07144735
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2027-12
- **Final completion:** 2030-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144735, "Allogeneic γδT Cells in Glioblastoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT07144735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*